vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
31.97
+2.57 (8.74%)
At close: Apr 28, 2026, 4:00 PM EDT
31.95
-0.02 (-0.06%)
After-hours: Apr 28, 2026, 5:26 PM EDT
vTv Therapeutics Employees
vTv Therapeutics had 26 employees as of December 31, 2025. The number of employees increased by 3 or 13.04% compared to the previous year.
Employees
26
Change (1Y)
3
Growth (1Y)
13.04%
Revenue / Employee
n/a
Profits / Employee
-$1,037,462
Market Cap
396.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Vanda Pharmaceuticals | 533 |
| Puma Biotechnology | 179 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
VTVT News
- 21 days ago - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - vTv Therapeutics to Participate in the 38th Annual ROTH Conference - GlobeNewsWire
- 7 weeks ago - vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 2 months ago - vTv Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewsWire
- 4 months ago - vTv Therapeutics and M42's IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health - GlobeNewsWire
- 6 months ago - vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - vTv Therapeutics Announces New Appointments to its Scientific Advisory Board - GlobeNewsWire